IL6 Cancer Research Results

IL6, Interleukin-6: Click to Expand ⟱
Source: HalifaxProj(inhibit)
Type:
Interleukin-6 (IL-6) is a cytokine that plays a significant role in inflammation and the immune response. It is produced by various cell types, including T cells, B cells, macrophages, and fibroblasts.
IL-6 can promote tumor cell proliferation and survival. Many cancer cells produce IL-6, which can create an autocrine loop that supports their growth.
IL-6 is a high-value inflammatory biomarker in cancer, reporting cytokine burden, catabolic stress, and STAT3-linked survival signaling. While not tumor-specific, elevated and rising IL-6 strongly predicts poor prognosis and limited treatment tolerance, making it an important system-state indicator alongside CRP and ferritin.



Cerv, Cervical Cancer: Click to Expand ⟱
Cervical Cancer

Scientific Papers found: Click to Expand⟱
3233- EGCG,    Epigallocatechin gallate inhibits HeLa cells by modulation of epigenetics and signaling pathways
- in-vitro, Cerv, HeLa
DNMTs↓, DNMT1↓, DNMT3A↓, HDAC2↓, HDAC3↓, HDAC4↓, EZH2↓, PI3K↓, Wnt↓, MAPK↓, hTERT/TERT↓, MMP2↓, MMP7↓, IL6↓, MDM2↓, MMP-10↓, TP53↑, PTEN↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Cell Death

hTERT/TERT↓, 1,   MAPK↓, 1,   MDM2↓, 1,  

Transcription & Epigenetics

EZH2↓, 1,  

DNA Damage & Repair

DNMT1↓, 1,   DNMT3A↓, 1,   DNMTs↓, 1,   TP53↑, 1,  

Proliferation, Differentiation & Cell State

HDAC2↓, 1,   HDAC3↓, 1,   HDAC4↓, 1,   PI3K↓, 1,   PTEN↑, 1,   Wnt↓, 1,  

Migration

MMP-10↓, 1,   MMP2↓, 1,   MMP7↓, 1,  

Immune & Inflammatory Signaling

IL6↓, 1,  

Clinical Biomarkers

EZH2↓, 1,   hTERT/TERT↓, 1,   IL6↓, 1,   TP53↑, 1,  
Total Targets: 22

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: IL6, Interleukin-6
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:29  Cells:%  prod#:%  Target#:158  State#:%  Dir#:1
wNotes=0 sortOrder:rid,rpid

 

Home Page